Tardive Dyskinesia
Dermatology·MeSH: Tardive Dyskinesia
3 drugs in development·3 companies·5 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 3(1)
| Drug | Company |
|---|---|
| nbi-1065890 | NEUROCRINE BIOSCIENCES INC (NBIX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Tardive Dyskinesia?
BioSniper tracks 3 drugs in development for Tardive Dyskinesia across 3 companies.
How many clinical trials target Tardive Dyskinesia?
There are 5 clinical trials targeting Tardive Dyskinesia tracked by BioSniper.
Deep-dive into Tardive Dyskinesia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis